General Information of the Protein
Protein ID
PT01343
Protein Name
Fibroblast growth factor receptor 4
Gene Name
FGFR4
Secondarily
Gene Name
JTK2
TKF
Sequence
MRLLLALLGVLLSVPGPPVLSLEASEEVELEPCLAPSLEQQEQELTVALGQPVRLCCGRAERGGHWYKEGSRLAPAGRVRGWRGRLEIASFLPEDAGRYLCLARGSMIVLQNLTLITGDSLTSSNDDEDPKSHRDPSNRHSYPQQAPYWTHPQRMEKKLHAVPAGNTVKFRCPAAGNPTPTIRWLKDGQAFHGENRIGGIRLRHQHWSLVMESVVPSDRGTYTCLVENAVGSIRYNYLLDVLERSPHRPILQAGLPANTTAVVGSDVELLCKVYSDAQPHIQWLKHIVINGSSFGADGFPYVQVLKTADINSSEVEVLYLRNVSAEDAGEYTCLAGNSIGLSYQSAWLTVLPEEDPTWTAAAPEARYTDIILYASGSLALAVLLLLAGLYRGQALHGRHPRPPATVQKLSRFPLARQFSLESGSSGKSSSSLVRGVRLSSSGPALLAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEEYLDLRLTFGPYSPSGGDASSTCSSSDSVFSHDPLPLGSSSFPFGSGVQT
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
TK protein kinase group
>
Tyrosine protein kinase FGFR family
Function
Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism and phosphate homeostasis. Required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. Phosphorylates PLCG1 and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes SRC-dependent phosphorylation of the matrix protease MMP14 and its lysosomal degradation. FGFR4 signaling is down-regulated by receptor internalization and degradation; MMP14 promotes internalization and degradation of FGFR4. Mutations that lead to constitutive kinase activation or impair normal FGFR4 inactivation lead to aberrant signaling.
    Show/Hide
Uniprot ID
Primary ID:
P22455

Secondarily ID:
G3JVM2
G3JVM5
G3JVM7
G3JVM9
O43785
Q14309
Q71TW8
Q8TDA0
Q96KE5
    Show/Hide
Ensembl ID
ENSG00000160867
HGNC ID
HGNC:3691
Subcellular Location
Cell membrane
Endosome
Endoplasmic reticulum
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000077 , Ba/F3
Compound ID Compound Name Compound Formula
CP0423457
N-[4-[(E)-2-[4-(4-methylpiperazin-1-yl)-6-[(5-propan-2-yl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]ethenyl]phenyl]prop-2-enamide
   Show/Hide
C26H32N8O
 1
1
GI50 = 6.4 nM
   TI
   LI
   LO
   TS
CP0441015
N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]propanamide
   Show/Hide
C30H31F3N6OS
 1
1
GI50 = 75 nM
   TI
   LI
   LO
   TS
CP0479968
1-[4-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]phenyl]piperidin-1-yl]prop-2-en-1-one
   Show/Hide
C27H34N8O
 1
1
GI50 = 438 nM
   TI
   LI
   LO
   TS
CP0219702
US9266883, 23
   Show/Hide
C19H19N5O4
 1
1
IC50 = 18 nM
   TI
   LI
   LO
   TS
CP0262125
US9266883, 26
   Show/Hide
C22H24N6O3
 1
1
IC50 = 24 nM
   TI
   LI
   LO
   TS
CP0231012
US9266883, 33
   Show/Hide
C19H19N5O3
 1
1
IC50 = 29 nM
   TI
   LI
   LO
   TS
CP0388620
methyl N-[4-[7-amino-3-(3,4-dimethoxyphenyl)-5-(1-methylpiperidin-4-yl)oxypyrazolo[1,5-a]pyrimidin-6-yl]phenyl]carbamate
   Show/Hide
C28H32N6O5
 1
1
IC50 = 35 nM
   TI
   LI
   LO
   TS
CP0482293
3-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-1-(6-formylpyridin-2-yl)-1-methylurea
   Show/Hide
C17H18N6O3
 1
1
IC50 = 41 nM
   TI
   LI
   LO
   TS
CP0189486
US9266883, 234
   Show/Hide
C18H17N5O3
 1
1
IC50 = 55 nM
   TI
   LI
   LO
   TS
CP0078209
US9266883, 13
   Show/Hide
C17H15N5O3
 1
1
IC50 = 72 nM
   TI
   LI
   LO
   TS
CP0231015
3-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-1-(6-formylpyridin-2-yl)-1-(2-methoxyethyl)urea
   Show/Hide
C19H22N6O4
 1
1
IC50 = 91 nM
   TI
   LI
   LO
   TS
CP0444841
US9266883, 3
   Show/Hide
C16H13N5O2
 1
1
IC50 = 108 nM
   TI
   LI
   LO
   TS
CP0069664
US9266883, 8
   Show/Hide
C15H12N6O2
 1
1
IC50 = 131 nM
   TI
   LI
   LO
   TS
CP0346996
US9266883, 31
   Show/Hide
C21H21N5O3
 1
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
CP0149294
(1S,2S,3R,4R)-3-[[5-cyano-2-[4-[4-(dimethylamino)piperidin-1-yl]-2-(2-methylpropoxy)anilino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide
   Show/Hide
C30H40N8O2
 1
1
IC50 = 162 nM
   TI
   LI
   LO
   TS
CP0262124
US9266883, 25
   Show/Hide
C20H20N6O3
 1
1
IC50 = 224 nM
   TI
   LI
   LO
   TS
CP0387357
US9266883, 14
   Show/Hide
C15H11F3N4O3
 1
1
IC50 = 531 nM
   TI
   LI
   LO
   TS
CP0069663
US9266883, 38
   Show/Hide
C20H22N6O3
 1
1
IC50 = 588 nM
   TI
   LI
   LO
   TS
CP0346997
US9266883, 202
   Show/Hide
C20H21N5O4
 1
1
IC50 = 741 nM
   TI
   LI
   LO
   TS
CP0149459
N-(5-cyano-4-propan-2-yloxypyridin-2-yl)-6-formylpyrrolo[2,3-b]pyridine-1-carboxamide
   Show/Hide
C18H15N5O3
 1
1
IC50 = 750 nM
   TI
   LI
   LO
   TS
CP0231011
US9266883, 4
   Show/Hide
C15H13ClN4O2
 1
1
IC50 = 916 nM
   TI
   LI
   LO
   TS
CP0418567
3-[4-amino-7-[3-(hydroxymethyl)cyclobutyl]pyrrolo[2,3-d]pyrimidin-5-yl]phenol
   Show/Hide
C17H18N4O2
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0061016
3-(4-Amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-phenol
   Show/Hide
C17H18N4O
 1
1
IC50 = 2400 nM
   TI
   LI
   LO
   TS
CP0078208
2-formyl-N-[5-(trifluoromethyl)pyridin-2-yl]quinoline-8-carboxamide
   Show/Hide
C17H10F3N3O2
 1
1
IC50 = 2755 nM
   TI
   LI
   LO
   TS
CP0149458
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-formyl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
   Show/Hide
C23H25N5O4
 1
1
IC50 = 2800 nM
   TI
   LI
   LO
   TS
CP0385511
1-[4-[6-[(2R)-2-(3-fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl]piperidin-4-ol
   Show/Hide
C26H27FN6O
 1
1
IC50 = 4400 nM
   TI
   LI
   LO
   TS
CP0388615
3-(3,4-dimethoxyphenyl)-5-(1-methylpiperidin-4-yl)oxy-6-(1,3-thiazol-2-yl)pyrazolo[1,5-a]pyrimidin-7-amine
   Show/Hide
C23H26N6O3S
 1
1
IC50 = 4400 nM
   TI
   LI
   LO
   TS
CP0385508
2-[4-[4-[6-[(2R)-2-(3-fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl]piperazin-1-yl]acetic acid
   Show/Hide
C27H28FN7O2
 1
1
IC50 = 5300 nM
   TI
   LI
   LO
   TS
CP0388864
4-[6-(benzylamino)imidazo[1,2-b]pyridazin-3-yl]benzonitrile
   Show/Hide
C20H15N5
 1
1
IC50 = 5900 nM
   TI
   LI
   LO
   TS
CP0395047
6-[(2R)-2-(3-fluorophenyl)pyrrolidin-1-yl]-3-pyridin-2-ylimidazo[1,2-b]pyridazine
   Show/Hide
C21H18FN5
 1
1
IC50 = 9200 nM
   TI
   LI
   LO
   TS
CP0388616
3-(3,4-dimethoxyphenyl)-5-(1-methylpiperidin-4-yl)oxy-6-phenylpyrazolo[1,5-a]pyrimidin-7-amine
   Show/Hide
C26H29N5O3
 1
1
IC50 > 11000 nM
   TI
   LI
   LO
   TS
CP0138866
1-[4-[3-[4-amino-5-(2-fluoro-5-hydroxyphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]piperazin-1-yl]ethanone
   Show/Hide
C22H25FN6O2
 1
1
IC50 > 11000 nM
   TI
   LI
   LO
   TS
CP0231013
US9266883, 11
   Show/Hide
C15H15N5O3
 1
1
IC50 > 3000 nM
   TI
   LI
   LO
   TS
CP0231014
US9266883, 201
   Show/Hide
C17H15N5O2
 1
1
IC50 > 3000 nM
   TI
   LI
   LO
   TS
CP0487228
7-formyl-N-(5-methyl-1H-pyrazol-3-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
   Show/Hide
C14H15N5O2
 1
1
IC50 > 3000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0120239
US10537571, Compound 108
   Show/Hide
C29H34Cl2N8O4
 2
1 IC50 < 0.2 nM
2 IC50 < 1.2 nM
CP0231012
US9266883, 33
   Show/Hide
C19H19N5O3
 1
1 IC50 = 0.7 nM
CP0189486
US9266883, 234
   Show/Hide
C18H17N5O3
 1
1 IC50 = 1.1 nM
CP0079069
N-[2-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl]amino]-3-methylphenyl]prop-2-enamide
   Show/Hide
C26H22Cl2N4O3
 6
1 IC50 = 1.16 nM
2 IC50 = 1.78 nM
3 IC50 = 3 nM
4 IC50 = 6.3 nM
5 IC50 = 14 nM
6 IC50 = 2324 nM
CP0262125
US9266883, 26
   Show/Hide
C22H24N6O3
 1
1 IC50 = 1.2 nM
CP0219702
US9266883, 23
   Show/Hide
C19H19N5O4
 1
1 IC50 = 1.3 nM
CP0069657
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-2-(prop-2-enoylamino)benzamide
   Show/Hide
C23H24N4O4
 1
1 IC50 = 1.5 nM
CP0531593
US9266883, 98
   Show/Hide
C24H27N7O5
 1
1 IC50 = 1.6 nM
CP0134300
US11136320, Reference Compound
   Show/Hide
C25H30N8O4
 3
1 IC50 = 1.9 nM
2 IC50 = 8.9 nM
3 IC50 = 12 nM
CP0189862
US9266883, 101
   Show/Hide
C25H29N7O5
 2
1 IC50 = 1.9 nM
2 IC50 > 10000 nM
CP0064283
Balversa
   Show/Hide
C25H30N6O2
 5
1 IC50 = 2 nM
2 IC50 = 5.7 nM
3 IC50 = 6.607 nM
4 IC50 < 10 nM
5 IC50 = 18.7 nM
CP0149294
(1S,2S,3R,4R)-3-[[5-cyano-2-[4-[4-(dimethylamino)piperidin-1-yl]-2-(2-methylpropoxy)anilino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide
   Show/Hide
C30H40N8O2
 1
1 IC50 = 2.2 nM
CP0149459
N-(5-cyano-4-propan-2-yloxypyridin-2-yl)-6-formylpyrrolo[2,3-b]pyridine-1-carboxamide
   Show/Hide
C18H15N5O3
 1
1 IC50 = 3.2 nM
CP0214140
2-[4-[(E)-2-[5-[(1R)-1-(3,5-dichloropyridin-4-yl)ethoxy]-1H-indazol-3-yl]ethenyl]pyrazol-1-yl]ethanol
   Show/Hide
C21H19Cl2N5O2
 2
1 IC50 = 3.2 nM
2 IC50 = 6 nM
CP0218526
US10618902, Compound I-281
   Show/Hide
C23H23F2N5O5
 1
1 IC50 = 4.5 nM
CP0563793
US10618902, Compound I-250
   Show/Hide
C22H23Cl2N5O6S
 1
1 IC50 = 6 nM
CP0078209
US9266883, 13
   Show/Hide
C17H15N5O3
 1
1 IC50 = 6.3 nM
CP0482293
3-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-1-(6-formylpyridin-2-yl)-1-methylurea
   Show/Hide
C17H18N6O3
 1
1 IC50 = 6.5 nM
CP0176348
US10618902, Compound I-279
   Show/Hide
C23H23ClFN5O5
 1
1 IC50 = 6.5 nM
CP0565334
US10189794, Compound I-241
   Show/Hide
C23H23Cl2N5O5
 1
1 IC50 = 6.5 nM
CP0231015
3-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-1-(6-formylpyridin-2-yl)-1-(2-methoxyethyl)urea
   Show/Hide
C19H22N6O4
 1
1 IC50 = 7.4 nM
CP0558520
US10618902, Compound I-294
   Show/Hide
C25H29N5O5
 1
1 IC50 = 10 nM
CP0069663
US9266883, 38
   Show/Hide
C20H22N6O3
 1
1 IC50 = 11 nM
CP0083239
BGJ398
   Show/Hide
C26H31Cl2N7O3
 4
1 IC50 = 13 nM
2 IC50 = 60 nM
3 IC50 = 71 nM
4 IC50 = 115 nM
CP0219703
US9266883, 1
   Show/Hide
C16H13F3N4O2
 2
1 IC50 = 13 nM
2 IC50 > 10000 nM
CP0322326
US10618902, Compound I-254
   Show/Hide
C23H24ClN5O5
 1
1 IC50 = 13 nM
CP0444841
US9266883, 3
   Show/Hide
C16H13N5O2
 1
1 IC50 = 16 nM
CP0346996
US9266883, 31
   Show/Hide
C21H21N5O3
 1
1 IC50 = 17 nM
CP0231011
US9266883, 4
   Show/Hide
C15H13ClN4O2
 1
1 IC50 = 21 nM
CP0149458
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-7-formyl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
   Show/Hide
C23H25N5O4
 1
1 IC50 = 23 nM
CP0262124
US9266883, 25
   Show/Hide
C20H20N6O3
 1
1 IC50 = 27 nM
CP0559896
US9266883, 12
   Show/Hide
C15H12N6O2
 1
1 IC50 = 33 nM
CP0387357
US9266883, 14
   Show/Hide
C15H11F3N4O3
 1
1 IC50 = 42 nM
CP0069664
US9266883, 8
   Show/Hide
C15H12N6O2
 1
1 IC50 = 45 nM
CP0054573
CHEBI:63453
   Show/Hide
C26H33N5O3
 5
1 IC50 = 45.7 nM
2 IC50 = 49.8 nM
3 IC50 = 56 nM
4 IC50 = 165 nM
5 IC50 = 2510 nM
CP0579914
N-[2-[[3-(3,5-dimethoxybenzoyl)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]phenyl]prop-2-enamide
   Show/Hide
C25H22N4O4
 1
1 IC50 = 51.6 nM
CP0198384
6-chloro-N-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-3-nitropyridin-2-amine
   Show/Hide
C11H5Cl2F3N4O2
 1
1 IC50 = 53 nM
CP0078208
2-formyl-N-[5-(trifluoromethyl)pyridin-2-yl]quinoline-8-carboxamide
   Show/Hide
C17H10F3N3O2
 2
1 IC50 = 57 nM
2 IC50 > 10000 nM
CP0661487
3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea monophosphate
   Show/Hide
C26H34Cl2N7O7P
 1
1 IC50 = 60 nM
CP0322325
N-[(1S,2R)-2-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)-8-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl]amino]cyclopentyl]prop-2-enamide
   Show/Hide
C24H25Cl2N5O4
 1
1 IC50 = 73 nM
CP0231013
US9266883, 11
   Show/Hide
C15H15N5O3
 1
1 IC50 = 140 nM
CP0346997
US9266883, 202
   Show/Hide
C20H21N5O4
 1
1 IC50 = 175 nM
CP0486123
US10618902, Compound I-255
   Show/Hide
C23H25N5O5
 1
1 IC50 = 588 nM
CP0231014
US9266883, 201
   Show/Hide
C17H15N5O2
 1
1 IC50 = 660 nM
CP0487228
7-formyl-N-(5-methyl-1H-pyrazol-3-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
   Show/Hide
C14H15N5O2
 1
1 IC50 = 790 nM
CP0558518
N-[(3R,4S)-4-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)-8-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl]amino]oxolan-3-yl]propanamide
   Show/Hide
C23H25Cl2N5O5
 1
1 IC50 = 2340 nM
CP0229508
US10189794, Compound I-240
   Show/Hide
C23H23Cl2N5O5
 1
1 IC50 = 3161 nM
CP0231016
N-[5-cyano-4-[2-(dimethylamino)ethoxy]pyridin-2-yl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
   Show/Hide
C19H22N6O2
 1
1 IC50 = 4400 nM
CP0579492
N-[2-[[3-(3,5-dimethoxybenzoyl)-1-methylpyrrolo[2,3-b]pyridin-6-yl]amino]phenyl]prop-2-enamide
   Show/Hide
C26H24N4O4
 1
1 IC50 > 1000 nM
CP0019908
BDBM50242742
   Show/Hide
C30H40ClN7O3S
 1
1 Kd = 110 nM
Clinical Information about the Protein
Target 1 ( FGFR4 messenger RNA (FGFR4 mRNA) )
Target Type Clinical trial Target
Disease 2 Target-related Diseases  2
1 Hepatocellular carcinoma [ICD-11: 2C12.02]
2 Retinoblastoma [ICD-11: 2D02.2]
Clinical Trial Drug(s) 3 Clinical Trial Drugs  3
1 FGF401 Phase 1/2
Hepatocellular carcinoma
2 BLU-554 Phase 1
Hepatocellular carcinoma
3 H3B-6527 Phase 1
Hepatocellular carcinoma
Discontinued Drug(s) 1 Discontinued Drug  1
1 PD-0183812 Terminated
Retinoblastoma
Target 2 ( Fibroblast growth factor receptor 4 (FGFR4) )
Target Type Clinical trial Target
Disease 1 Target-related Disease  1
1 Solid tumour/cancer [ICD-11: 2A00-2F9Z]
Investigative Drug(s) 1 Investigative Drug  1
1 ACTB-1003 Investigative
Solid tumour/cancer
Similar Protein(s) and Bioactivity Statistics
50% Identity
Protein ID Protein Name Protein Organism
PT07029 Fibroblast growth factor receptor 4 Mus musculus, Mouse